Targeting defective DNA repair in prostate cancer.

Current Opinion in Oncology
Juliet CarmichaelJohann de Bono

Abstract

Prostate cancer is the second leading cause of cancer death in men. Characterization of the genomic landscape of prostate cancer has demonstrated frequent aberrations in DNA repair pathways, identifiable in up to 25% patients with metastatic disease, which may sensitize to novel therapies, including PARP inhibitors and immunotherapy. Here, we summarize the current clinical landscape and future horizons for targeting defective DNA repair pathways in PC. Several clinical trials have demonstrated efficacy of different PARP inhibitors in metastatic castration-resistant prostate cancer (mCRPC), most pronounced in those with BRCA mutations. The PROfound trial is the first positive phase 3 biomarker-selected trial to demonstrate improved outcomes with a targeted treatment, Olaparib, in mCRPC. Whilst the Keynote-199 trial failed to demonstrate efficacy of immune-checkpoint inhibitor pembrolizumab in unselected mCRPC patients, there was evidence of response in those harbouring DNA repair defects. These landmark trials represent a significant advance towards personalization of PC therapy. However, resistance remains inevitable and there is a lack of reliable predictive biomarkers to select patients for treatment. Characterization of resi...Continue Reading

References

May 11, 1999·JAMA : the Journal of the American Medical Association·C R PoundP C Walsh
Sep 5, 2013·Cold Spring Harbor Perspectives in Biology·Alexandre Maréchal, Lee Zou
Nov 10, 2013·Nature Medicine·Christopher J Lord, Alan Ashworth
Sep 26, 2014·Nature Communications·Colin C PritchardPeter S Nelson
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
Oct 29, 2015·The New England Journal of Medicine·Joaquin MateoJohann S de Bono
Jul 20, 2016·The New England Journal of Medicine·Colin C PritchardPeter S Nelson
Mar 18, 2017·Science·Christopher J Lord, Alan Ashworth
Apr 30, 2017·Cancer Discovery·Jane GoodallUNKNOWN TOPARP-A investigators
Mar 30, 2018·Expert Opinion on Emerging Drugs·Eric S Christenson, Emmanuel S Antonarakis
Apr 4, 2018·Nature Genetics·Joshua ArmeniaEliezer M Van Allen
Jun 30, 2018·Nature Reviews. Clinical Oncology·Alan Ashworth, Christopher J Lord
Sep 5, 2018·The Journal of Clinical Investigation·Daniel Nava RodriguesJohann S de Bono
May 10, 2019·World Journal of Oncology·Prashanth Rawla
May 18, 2019·American Society of Clinical Oncology Educational Book·Timothy A YapThomas Helleday
Jun 21, 2019·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J MateoJ S de Bono
Nov 28, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emmanuel S AntonarakisJohann Sebastian de Bono
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J MateoJ S de Bono
Apr 29, 2020·The New England Journal of Medicine·Johann de BonoMaha Hussain

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.